Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Wang Y.,,CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer,2015,Cell,167,10.1016/j.cell.2015.08.063,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-84943784340
Chen J.,,Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways,2015,Archives of Biochemistry and Biophysics,23,10.1016/j.abb.2014.11.008,China,Article,Beijing,0,Journal,2-s2.0-84928008162
Liu R.,,DNMT1-microrna126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-akt signaling,2015,Clinical Cancer Research,69,10.1158/1078-0432.CCR-14-1740,China;China,Article,Shanghai;Shanghai,1,Journal,2-s2.0-84923148839
Cui X.,,DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis,2015,Cancer Letters,16,10.1016/j.canlet.2014.11.041,South Korea,Article,Seoul,0,Journal,2-s2.0-84920380990
Sato F.,,EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition,2015,Cancer Biology and Therapy,30,10.1080/15384047.2015.1040959,Japan,Article,Sapporo,1,Journal,2-s2.0-84943758352
Mansour M.R.,,An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element,2014,Science,334,10.1126/science.1259037,United Kingdom;United States,Article,London;Boston,0,Journal,2-s2.0-84917710235
Christensen C.,,Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor,2014,Cancer Cell,193,10.1016/j.ccell.2014.10.019,United States,Article,Boston,1,Journal,2-s2.0-84919495606
Chipumuro E.,,CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer,2014,Cell,261,10.1016/j.cell.2014.10.024,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-84911942289
Wang X.T.,,"BIIB021, a novel Hsp90 inhibitor, sensitizes esophageal squamous cell carcinoma to radiation",2014,Biochemical and Biophysical Research Communications,8,10.1016/j.bbrc.2014.09.026,China,Article,Jinan,0,Journal,2-s2.0-84907887815
Gao Y.B.,,Genetic landscape of esophageal squamous cell carcinoma,2014,Nature Genetics,295,10.1038/ng.3076,China,Article,Beijing,0,Journal,2-s2.0-84922068082
Lin D.C.,,Targeting genetic lesions in esophageal cancer,2014,Cell Cycle,8,10.4161/cc.29458,Singapore;United States,Editorial,Singapore City;Los Angeles,1,Journal,2-s2.0-84903641491
Watanabe H.,,SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas,2014,Journal of Clinical Investigation,75,10.1172/JCI71545,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-84897540725
Ui T.,,The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway,2014,Oncology Reports,18,10.3892/or.2013.2899,Japan,Article,Kawachi District,1,Journal,2-s2.0-84892421459
Qi M.,,DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner,2014,Biochimica et Biophysica Acta - Gene Regulatory Mechanisms,10,10.1016/j.bbagrm.2013.12.003,China,Article,Changsha,0,Journal,2-s2.0-84891424359
Amaral P.,,Re-place your BETs: The dynamics of super enhancers,2014,Molecular Cell,12,10.1016/j.molcel.2014.10.008,United Kingdom,Short Survey,Cambridge,1,Journal,2-s2.0-84922272208
Lin D.C.,,Genomic and molecular characterization of esophageal squamous cell carcinoma,2014,Nature Genetics,283,10.1038/ng.2935,Singapore;United States,Article,Singapore City;Los Angeles,0,Journal,2-s2.0-84899628626
Kwiatkowski N.,,Targeting transcription regulation in cancer with a covalent CDK7 inhibitor,2014,Nature,341,10.1038/nature13393,United States;United States;United States,Article,Cambridge;Boston;Boston,0,Journal,2-s2.0-84904963991
Song Y.,,Identification of genomic alterations in oesophageal squamous cell cancer,2014,Nature,505,10.1038/nature13176,China,Article,Beijing,0,Journal,2-s2.0-84899747138
Chapuy B.,,Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma,2013,Cancer Cell,385,10.1016/j.ccr.2013.11.003,United States,Article,Boston,1,Journal,2-s2.0-84891953718
Hnisz D.,,XSuper-enhancers in the control of cell identity and disease,2013,Cell,1378,10.1016/j.cell.2013.09.053,United States,Article,Cambridge,1,Journal,2-s2.0-84888015137
Shi Z.Z.,,Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization,2013,Clinical Cancer Research,46,10.1158/1078-0432.CCR-12-3753,China,Article,Beijing,1,Journal,2-s2.0-84887127381
Huang Y.,,A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin,2013,Anti-Cancer Drugs,20,10.1097/CAD.0b013e328363c64e,China,Article,Wuhan,0,Journal,2-s2.0-84883462981
Gen Y.,,SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway,2013,Cancer Science,42,10.1111/cas.12155,Japan,Article,Kyoto,0,Journal,2-s2.0-84880715864
Lov√©n J.,,Selective inhibition of tumor oncogenes by disruption of super-enhancers,2013,Cell,1209,10.1016/j.cell.2013.03.036,United States,Article,Cambridge,1,Journal,2-s2.0-84876222028
Tabusa H.,,Knockdown of PAK4 or PAK1 inhibits the mroliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling,2013,Molecular Cancer Research,56,10.1158/1541-7786.MCR-12-0466,United Kingdom,Article,Winnersh,1,Journal,2-s2.0-84874424655
Tyner J.W.,,Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening,2013,Cancer Research,95,10.1158/0008-5472.CAN-12-1906,United States,Article,Portland,1,Journal,2-s2.0-84871982053
Pennathur A.,,Oesophageal carcinoma,2013,The Lancet,1254,10.1016/S0140-6736(12)60643-6,United States,Conference Paper,Pittsburgh,0,Journal,2-s2.0-84873197641
Bicocca V.T.,,Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia,2012,Cancer Cell,100,10.1016/j.ccr.2012.08.027,United States,Article,Portland,1,Journal,2-s2.0-84869049935
Larochelle S.,,Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II,2012,Nature Structural and Molecular Biology,186,10.1038/nsmb.2399,United States,Article,New York,0,Journal,2-s2.0-84869095110
Scheitz C.,,Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer,2012,EMBO Journal,82,10.1038/emboj.2012.270,United States,Article,Ithaca,0,Journal,2-s2.0-84868530288
Agrawal N.,,Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma,2012,Cancer Discovery,231,10.1158/2159-8290.CD-12-0189,United States;United States,Article,Baltimore;,1,Journal,2-s2.0-84867398217
Dulak A.M.,,"Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis",2012,Cancer Research,183,10.1158/0008-5472.CAN-11-3893,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-84865238936
Zhou Q.,,RNA polymerase II elongation control,2012,Annual Review of Biochemistry,326,10.1146/annurev-biochem-052610-095910,United States,Article,Berkeley,0,Book Series,2-s2.0-84861857476
Zhang J.,,"LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells",2012,Cancer Letters,65,10.1016/j.canlet.2011.11.007,China,Article,Shenyang,0,Journal,2-s2.0-84856352028
Zhang Y.,,Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells,2012,Gastroenterology,59,10.1053/j.gastro.2011.11.023,China,Article,Beijing,0,Journal,2-s2.0-84857636386
Wang L.,,Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression,2011,Proceedings of the National Academy of Sciences of the United States of America,78,10.1073/pnas.1103423108,United States,Article,Charlottesville,1,Journal,2-s2.0-80053645783
Liu S.G.,,Atypical protein kinase Ci (PKCi) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to anoikis via PKCi-SKP2-AKT Pathway,2011,Molecular Cancer Research,27,10.1158/1541-7786.MCR-10-0359,China,Article,Beijing,1,Journal,2-s2.0-79954567234
Siu M.,,"p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients",2010,Proceedings of the National Academy of Sciences of the United States of America,135,10.1073/pnas.0907481107,Hong Kong,Article,Pokfulam,1,Journal,2-s2.0-78649880786
Gu J.,,Genome-wide catalogue of chromosomal aberrations in Barrett's esophagus and esophageal adenocarcinoma: A high-density single nucleotide polymorphism array analysis,2010,Cancer Prevention Research,58,10.1158/1940-6207.CAPR-09-0265,United States,Article,Houston,1,Journal,2-s2.0-77956402130
Murray B.,,Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth,2010,Proceedings of the National Academy of Sciences of the United States of America,182,10.1073/pnas.0911863107,United States,Article,New York,1,Journal,2-s2.0-77952720804
Hoi C.S.L.,,Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin,2010,Molecular and Cellular Biology,70,10.1128/MCB.01308-09,United States,Article,Ithaca,1,Journal,2-s2.0-77952005330
Zhao P.,,Cancer Trends in China,2010,Japanese Journal of Clinical Oncology,289,10.1093/jjco/hyp187,China,Review,Beijing,1,Journal,2-s2.0-77951232926
Li B.,,Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway,2009,International Journal of Cancer,86,10.1002/ijc.24675,Hong Kong,Article,,1,Journal,2-s2.0-70350704818
Bass A.J.,,SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas,2009,Nature Genetics,657,10.1038/ng.465,United States;United States;United States,Article,Boston;Boston;Cambridge,0,Journal,2-s2.0-70350641014
Du X.L.,,Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma,2009,Oncogene,57,10.1038/onc.2009.237,China,Article,Beijing,1,Journal,2-s2.0-70350566519
Luo M.L.,,Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance,2006,Cancer Research,114,10.1158/0008-5472.CAN-06-1484,China,Article,Beijing,1,Journal,2-s2.0-33846225205
Richardson R.J.,,Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch,2006,Nature Genetics,206,10.1038/ng1894,United Kingdom;United Kingdom,Article,Manchester;Manchester,0,Journal,2-s2.0-33750441851
Truong A.,,p63 regulates proliferation and differentiation of developmentally mature keratinocytes,2006,Genes and Development,317,10.1101/gad.1463206,,Article,,1,Journal,2-s2.0-33751230475
He Y.t.,,"Study on the esophageal cancer incidence and mortality rate from 1974-2002 in Cixian, China",2006,Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,9,,China,Article,Shijiazhuang,0,Journal,2-s2.0-65449134500
Xie J.,,Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells,2005,Biochemical and Biophysical Research Communications,81,10.1016/j.bbrc.2005.09.055,China,Article,Shantou,0,Journal,2-s2.0-25844474348
Oishi Y.,,Kr√ºppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation,2005,Cell Metabolism,303,10.1016/j.cmet.2004.11.005,Japan,Article,Tokyo,1,Journal,2-s2.0-20144389501
